Cannabidiol (CBD), one of the most promising constituents isolated from Cannabis sativa,
exhibits diverse pharmacological actions. However, the applications of CBD are restricted …

Microbial production of cannabinoids promises to provide a consistent, cheaper, and more
sustainable supply of these important therapeutic molecules. However, scaling production to …

Summary Identification of CBD, Δ9-THC, and the endocannabinoid system in the mid-20th
century has led to advancement of cannabis-based therapies for epilepsy. Based on clinical …

Cannabinoid-based interventions are being explored for central nervous system (CNS)
pathologies such as neurodegeneration, demyelination, epilepsy, stroke, and trauma. As …

Widespread legalisation of marijuana raises safety concerns for its use in pregnancy. This
study investigated the association of marijuana use prior to and during pregnancy with …

Despite the introduction of new antiepileptic drugs (AEDs), the quality of life and therapeutic
response for patients with epilepsy remains still poor. Unfortunately, besides several …

Ethnopharmacological relevance Epilepsy is one of the most prevalent neurological human
diseases, affecting 1% of the population in all age groups. Despite the availability of over 25 …

Despite its controversial nature, the use of medical marijuana and cannabis-derived
medicinal products grows more popular with each passing year. As of November 2016, over …

Cannabis has been used to treat convulsions and other disorders since ancient times. In the
last few decades, preclinical animal studies and clinical investigations have established the …

Cannabinoids are the derivatives of the cannabis plant, the most potent bioactive
component of which is tetrahydrocannabinol (THC). The most commonly used drugs …